Identification of invasive fungal diseases in immunocompromised patients by combining an Aspergillus specific PCR with a multifungal DNA‐microarray from primary clinical samples

By  

MYCOSES (ELECTRONIC), Vol. 58, Iss. 12, 2015-12 ,pp. : 735-745

John Wiley & Sons Inc

Access to resources Recommend Favorite

The in-vitro antimicrobial activities of some medicinal plants from Cameroon

By Gangoué-Piéboji J.   Pegnyemb D. E.   Niyitegeka D.   Nsangou A.   Eze N.   Minyem C.   Mbing J. Ngo   Ngassam P.   Tih R. Ghogomu   Sodengam B. L.   Bodo B.  

Annals of Tropical Medicine and Parasitology, Vol. 100, Iss. 3, 2006-04 ,pp. : 237-243

Maney Publishing

Access to resources Recommend Favorite

In vitro susceptibility of isolates of Francisella tularensis from Turkey

By Kiliç Selçuk   Çelebi Bekir   Acar Bülent   Ataş Mehmet  

Scandinavian Journal of Infectious Diseases, Vol. 45, Iss. 5, 2013-05 ,pp. : 337-341

Informa Healthcare

Access to resources Recommend Favorite

Identification of novel psychoactive drug use in Sweden based on laboratory analysis – initial experiences from the STRIDA project

By Helander Anders   Beck Olof   Hägerkvist Robert   Hultén Peter  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 73, Iss. 5, 2013-08 ,pp. : 400-406

Informa Healthcare

Access to resources Recommend Favorite

First proof of pharmacology in humans of a novel glucagon receptor antisense drug

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 3, 2015-03 ,pp. : 298-306

John Wiley & Sons Inc

Access to resources Recommend Favorite